Yukio Sakiyama
Overview
Explore the profile of Yukio Sakiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
331
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shinjoh M, Sakiyama Y, Sekiguchi S, Takahashi T
SAGE Open Med Case Rep
. 2017 Oct;
5:2050313X17736421.
PMID: 29051818
Context: Immunoglobulin G2 deficiency that persists beyond the age of 6 years is likely to be permanent. Case Report: We report on a young Japanese female, diagnosed as having immunoglobulin...
2.
Otsu M, Yamada M, Nakajima S, Kida M, Maeyama Y, Hatano N, et al.
J Clin Immunol
. 2015 Apr;
35(4):384-98.
PMID: 25875699
Objective: We here describe treatment outcomes in two adenosine deaminase (ADA)-deficiency patients (pt) who received stem cell gene therapy (SCGT) with no cytoreductive conditioning. As this protocol has features distinct...
3.
Maeyama Y, Otsu M, Kubo S, Yamano T, Iimura Y, Onodera M, et al.
Int J Oncol
. 2011 May;
39(1):41-9.
PMID: 21573489
Estrogen receptor-binding fragment-associated antigen 9 (EBAG9) is a tumor-promoting factor of largely unknown function. To assess a causative role of EBAG9 in advanced malignancies, we generated the EG7-OVA and MethA...
4.
Fujioka H, Ariga T, Horiuchi K, Ishikiriyama S, Oyama K, Otsu M, et al.
Pediatr Int
. 2008 Dec;
50(6):806-9.
PMID: 19067896
Background: Treacher Collins syndrome (TCS) is a disorder of craniofacial development, that is caused by mutations in the TCOF1 gene. TCS is inherited as an autosomal dominant trait, and haploinsufficiency...
5.
Nakajima M, Yamada M, Yamaguchi K, Sakiyama Y, Oda A, Nelson D, et al.
Eur J Haematol
. 2008 Nov;
82(3):223-30.
PMID: 19018864
The Wiskott-Aldrich syndrome protein (WASP), which is defective in Wiskott-Aldrich syndrome (WAS) patients, is an intracellular protein expressed in non-erythroid hematopoietic cells. Previously, we have established methods to detect intracellular...
6.
Kida M, Fujioka H, Kosaka Y, Hayashi K, Sakiyama Y, Ariga T
Blood Cells Mol Dis
. 2008 Jan;
40(3):410-3.
PMID: 18201916
The complement system is an ancient cascade system that has a major role in innate and adaptive immunity. Component C3 is central to the three complement pathways. Hereditary compliment 3...
7.
Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al.
Immunity
. 2006 Nov;
25(5):745-55.
PMID: 17088085
Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family. Here we identified a homozygous Tyk2 mutation in a patient who had been...
8.
Nakamura H, Sawamura D, Goto M, Nakamura H, Kida M, Ariga T, et al.
Int J Mol Med
. 2006 Jul;
18(2):333-7.
PMID: 16820943
Non-Herlitz junctional epidermolysis bullosa (nH-JEB) disease manifests with skin blistering, atrophy and tooth enamel hypoplasia. The majority of patients with nH-JEB harbor mutations in COL17A1, the gene encoding type XVII...
9.
Fujioka H, Ariga T, Yoda M, Ohsaki M, Horiuchi K, Otsu M, et al.
Am J Med Genet A
. 2005 Sep;
138(4):399-400.
PMID: 16158444
No abstract available.
10.
Sakiyama Y, Ariga T, Ohtsu M
Nihon Rinsho
. 2005 Mar;
63(3):448-52.
PMID: 15773344
A four year-old boy with adenosine deaminase (ADA-) deficient severe combined immunodeficiency(SCID) receiving PEG-ADA was treated under a gene therapy protocol targeting peripheral blood lymphocytes (PBLs) in 1995. After eleven...